a3137-25 spinal 25g whitacre - regional anesthesia kit
smiths medical asd, inc. - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. marcaine spinal is indicated for the production of subarachnoid block (spinal anesthesia). standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia. marcaine spinal is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type. the following conditions preclude the use of spinal anesthesia: - severe hemorrhage, severe h
a3893-24 spinal 24g gertie marx spinal with introducer - regional anesthesia kit
smiths medical asd, inc. - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. marcaine spinal is indicated for the production of subarachnoid block (spinal anesthesia). standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia. marcaine spinal is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type. the following conditions preclude the use of spinal anesthesia: - severe hemorrhage, severe h
marcaine adrenaline 0.5 %
tec-o-pharm-libra ltd - bupivacaine hydrochloride 5 mg/ml; epinephrine as tartrate 5.5 mcg/ml - solution for injection - bupivacaine - nerve blocks of long duration where substantial muscle relaxation is not a requirement e.g. in obstetrics, for postoperative pain relief and also therapeutic and diagnostic blocks.
marcaine spinal 0.5 % heavy amp.
astra zeneca-egypt - injection - 0.5 %
marcaine 0.5% 5mg / ml solution for injection
pfizer, inc.; distributor: pfizer, inc. - bupivacaine hydrochloride - solution for injection - 5mg / ml
marcaine 0.25% liq prt 2.5mg/ml liquid
sanofi canada, inc. - bupivacaine hydrochloride - liquid - 2.5mg - bupivacaine hydrochloride 2.5mg - local anesthetics
marcaine 0.75% liq prt 7.5mg/ml liquid
sanofi canada, inc. - bupivacaine hydrochloride - liquid - 7.5mg - bupivacaine hydrochloride 7.5mg - local anesthetics
marcaine e liq prt 0.50% liquid
sanofi canada, inc. - bupivacaine hydrochloride; epinephrine bitartrate - liquid - 5mg; 9.1mcg - bupivacaine hydrochloride 5mg; epinephrine bitartrate 9.1mcg - local anesthetics
marcaine e 0.25% liq prt liquid
sanofi canada, inc. - bupivacaine hydrochloride; epinephrine bitartrate - liquid - 2.5mg; 9.1mcg - bupivacaine hydrochloride 2.5mg; epinephrine bitartrate 9.1mcg - local anesthetics
marcaine 0.50% liq bin 5mg/ml liquid
sanofi canada, inc. - bupivacaine hydrochloride - liquid - 5mg - bupivacaine hydrochloride 5mg - local anesthetics